- Delivering Pan India
Verquvo® (Vericiguat) Vericiguat 2.5 mg and Vericiguat 5 mg and Vericiguat 10 mg film-coated tablets by Bayer. Genuine stock supplied in bulk/wholesale quantities to hospitals and pharmacies across India by A.K. Pharma, a licensed pharmaceutical distributor in Delhi.
| Composition | Vericiguat 2.5 mg / Vericiguat 5 mg / Vericiguat 10 mg |
|---|---|
| Manufacturer | Bayer |
| Country | Germany |
| Pack size | Vericiguat 2.5 mg: 14 tablets (as shown on the carton); Vericiguat 5 mg: 14 tablets (as shown on the carton); Vericiguat 10 mg: 14 tablets (11 tablets + 3 free tablets, as shown on the carton) |
| Storage | Store below 30°C as printed on the carton; the US reference label describes 20°C to 25°C. |
Supplied only against a valid prescription from a registered medical practitioner.
Sourced from authorised channels
Temperature-controlled packing
Hospitals, clinics, pharmacies
Delhi drug licence holder
Verquvo® (Vericiguat) Vericiguat 2.5 mg and Vericiguat 5 mg and Vericiguat 10 mg Film-coated Tablets — Oral Soluble Guanylate Cyclase (sGC) Stimulator Tablets: A Sourcing Guide for Hospitals and Pharmacies
Verquvo® is a brand of vericiguat film-coated tablets from Bayer, imported and marketed in India by Bayer Zydus Pharma as shown on the carton. According to the current US prescribing information, vericiguat is a soluble guanylate cyclase (sGC) stimulator indicated to reduce the risk of cardiovascular death and heart-failure hospitalisation following a hospitalisation for heart failure or need for outpatient IV diuretics, in adults with symptomatic chronic heart failure and ejection fraction less than 45%. Indications in India are defined by its approved pack insert and the Indian regulator. The decision to prescribe vericiguat, including patient selection, dose and monitoring, rests entirely with the treating physician. This page provides sourcing and procurement information for hospitals and pharmacies, not clinical or treatment guidance.
As both a trusted medicine distributor in Delhi and a licensed pharmaceutical distributor in Delhi, A.K. Pharma supplies genuine Verquvo® (vericiguat) Vericiguat 2.5 mg and Vericiguat 5 mg and Vericiguat 10 mg film-coated tablets to hospitals and pharmacies across India. Buyers comparing pharmaceutical distribution companies and wholesale pharmaceutical distributors can also browse our full product range and the heart medicines category. Supply is in bulk/wholesale quantities only.
Verquvo contains vericiguat in 2.5 mg, 5 mg and 10 mg film-coated tablets, supplied in the pack sizes listed below.
How it works, according to the label: The reference label describes vericiguat as a soluble guanylate cyclase (sGC) stimulator that acts on the nitric oxide–sGC–cyclic GMP pathway.
The current US prescribing information for VERQUVO® (vericiguat) tablets (DailyMed) lists the following. Indications in India may differ and are defined by the Indian regulator and the Verquvo pack insert.
The reference label summarises its Clinical Studies in heart failure with reduced ejection fraction. The VICTORIA study of vericiguat was published by Armstrong et al. in the New England Journal of Medicine in 2020. Evidence is cited for information only and is not a recommendation for any patient; the approved prescribing information governs.
| Strength | Dosage form | Pack size (as shown on the carton) |
|---|---|---|
| Vericiguat 2.5 mg | Film-coated tablets | 14 tablets (as shown on the carton) |
| Vericiguat 5 mg | Film-coated tablets | 14 tablets (as shown on the carton) |
| Vericiguat 10 mg | Film-coated tablets | 14 tablets (11 tablets + 3 free tablets, as shown on the carton) |
Please confirm the current pack and batch with us before ordering. Dose and regimen must be determined and followed exactly as directed by the treating physician and the approved prescribing information.
This page is written for hospital pharmacists, cardiology department buyers and pharmacies that source heart-failure products. Vericiguat is prescribed and supervised by a physician, as described in the prescribing information.
The reference label carries a boxed warning for embryo-fetal toxicity. It lists hypotension and anaemia as the most common adverse reactions (5% or more). This list is not complete; the full prescribing information governs.
All use should follow the approved prescribing information and the instructions of the treating physician.
Please follow the storage instructions printed on the Verquvo carton and blister. The carton in this range advises storage below 30°C. For reference, the US label describes 20°C to 25°C. Keep out of reach of children.
Verquvo is marketed by Bayer. A.K. Pharma is a licensed distributor and does not manufacture the product. As one of the pharmaceutical distributors serving Indian hospitals, we source Verquvo through authorised channels and supply it with pack and batch details. Buyers comparing a pharmaceutical wholesale distributors list or a pharma distribution company can verify our credentials on the About Us page.
Is Verquvo available in India?
A.K. Pharma supplies Verquvo (vericiguat) Vericiguat 2.5 mg and Vericiguat 5 mg and Vericiguat 10 mg film-coated tablets to hospitals and pharmacies in India. Contact us for current availability.
What does Verquvo contain?
Vericiguat, a soluble guanylate cyclase stimulator, in 2.5 mg, 5 mg and 10 mg film-coated tablets.
Can I order a single pack?
A.K. Pharma is a distributor and supplies bulk/wholesale quantities only, not one or two pieces.
How should Verquvo be stored?
Follow the carton and blister; the Indian carton advises below 30°C and the US label describes 20°C to 25°C.
Does A.K. Pharma advise on dosing or suitability?
No. Treatment decisions, including dosing, rest solely with the treating physician and the approved prescribing information.
How do I request a quote?
Call or WhatsApp us, or use the contact details below.
📍 E-2/257A, 2nd Floor, Shastri Nagar, New Delhi 110052
📞 011 4172 6999
📱 WhatsApp: +91 9810034827
🌐 akpharma.in
Disclaimer: This page is intended for informational and sourcing/procurement purposes only and does not constitute medical or clinical advice. A.K. Pharma is a licensed medicine distributor, not a healthcare provider, and does not provide clinical guidance. All treatment decisions, including drug selection and dosing, rest solely with the treating physician and should follow the approved prescribing information.
